Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Short squeeze stocks are a subject frequently mentioned on social media, and rightfully so. A short squeeze occurs when a heavily shorted stock moves higher. As the stock moves higher, traders who shorted the company must b...
RenovoRx (NASDAQ:RNXT): Q3 net loss of $1.5M. Press Release As of September 30, 2021, the Company had cash and cash equivalents of $17.7 million and no outstanding debt obligations. For further details see: RenovoRx reports Q3 results
RenovoRx , Inc. (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today reported its unaudited financial results for the third quarter ended September 30, 2021. “The third quarter of 2021 marked an important juncture in the growth o...
Study Results Validate Potential for Intra-arterial Chemotherapy Delivery for the Treatment of Pancreatic Cancer RenovoRx , Inc. (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today announced that it will be presenting an ePoste...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Fisker (NYSE: FSR ) investors are going to want to keep an eye on FSR stock when Nov. 17 rolls around next Wednesday. Source: T. Schneider / Shutterstock.com A major catalyst for the stock could come that day ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips RenovoRx (NASDAQ: RNXT ) stock is rocketing higher today thanks to a presentation of data at a recent medical conference. Source: Shutterstock Let’s dive into that news below! Dr. Ripal Gandhi made a...
RenovoRx (NASDAQ:RNXT) +68% after presentation on treatment platform RingCentral (NYSE:RNG) +26% after boosting full-year revenue outlook; buys Mitel's IP rights and patents Valneva SE American Depositary (NASDAQ:VALN) +25% on European nod to procure up to 60M do...
Nano-cap biopharmaceutical company, RenovoRx (NASDAQ:RNXT) has added ~53.5% in the pre-market on above-average volume after the company made a presentation on its therapeutic platform on Tuesday evening. Nearly 4 million RenovoRx (RNXT) shares have changed hands in early trading, mo...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! It’s time to start another busy day of trading with a dive into the biggest pre-market stock movers for Wednesday. Source: Shutterstock We’re deep into earnings with most of the s...
RenovoRx Phase 3 TIGeR-PaC Clinical Trial Preliminary Pharmacokinetic Data Featured RenovoRx, Inc. (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today announced its novel therapy platform, RenovoTAMP TM (RenovoRx Trans-Arterial Mic...
News, Short Squeeze, Breakout and More Instantly...
LOS ALTOS, Calif., July 08, 2024 (GLOBE NEWSWIRE) -- RenovoRx, Inc . (“RenovoRx” or the “Company”) (Nasdaq: RNXT) , a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, today annou...
LOS ALTOS, Calif., June 26, 2024 (GLOBE NEWSWIRE) -- RenovoRx, Inc . (“RenovoRx” or the “Company”) (Nasdaq: RNXT) , a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, announced t...
LOS ALTOS, Calif., June 10, 2024 (GLOBE NEWSWIRE) -- RenovoRx, Inc . (“RenovoRx” or the “Company”) (Nasdaq: RNXT) , a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, announced t...